Joseph Shulman, Chief Technical Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 28,874 shares at $112.81 ($3.2M) on 2025-10-16, disclosed to the SEC on 2025-10-20.
Scheduled sale ($3.2M) by Chief Technical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.95 | 2,693 | $299K | 9.2% |
| 2 | $110.95 | 2,693 | $299K | 9.2% |
| 3 | $112.06 | 8,332 | $934K | 28.9% |
| 4 | $112.06 | 8,332 | $934K | 28.9% |
| 5 | $112.81 | 3,412 | $385K | 11.9% |
| 6 | $112.81 | 3,412 |
| $385K |
| 11.9% |
| Total | $112.03 avg | 28,874 | $3.2M | 100% |
| Filing → |
| RYTM | SELL | 2025-10-30 | $648K | — | Filing → |
| RYTM | SELL | 2025-09-04 | $3.5M | — | Filing → |
| RYTM | SELL | 2025-08-25 | $838K | — | Filing → |